Class IA phosphoinositide 3-kinase (PI3K) are enzymes comprised of a p85 regulatory and a p110 catalytic subunit that induce formation of 3-polyphosphoinositides, which activate numerous downstream targets. PI3K controls cell division. Of the 2 ubiquitous PI3K isoforms, ␣ has selective action in cell growth and cell cycle entry, but no specific function in cell division has been described for ␤. We report here a unique function for PI3K␤ in the control of DNA replication. PI3K␤ regulated DNA replication through kinase-dependent and kinase-independent mechanisms. PI3K␤ was found in the nucleus, where it associated PKB. Modulation of PI3K␤ activity altered the DNA replication rate by controlling proliferating cell nuclear antigen (PCNA) binding to chromatin and to DNA polymerase ␦. PI3K␤ exerted this action by regulating the nuclear activation of PKB in S phase, and in turn phosphorylation of PCNA negative regulator p21 Cip . Also, p110␤ associated with PCNA and controlled PCNA loading onto chromatin in a kinase-independent manner. These results show a selective function of PI3K␤ in the control of DNA replication.
C
lass I A phosphoinositide 3-kinase (PI3K) is an enzyme that controls cell cycle entry. Mutations in this pathway are among the most frequent events in human cancer; a mayor objective in translational biology is to define PI3K isoformspecific functions. The PI3K are comprised of a p85 regulatory and a p110 catalytic subunit that mediates formation of 3-polyphosphoinositides (1, 2). There are three class I A p110 catalytic subunits (␣, ␤ and ␦), but only p110␣ and ␤ are ubiquitous and essential for development (3, 4) ; enhanced p110␣ and ␤ activity trigger cell transformation (5) . p110␣ regulates cell growth and cell cycle entry (6) . In the case of p110␤, the recent description of p110␤ conditional knockout mouse phenotype shows that p110␤ activity is essential for animal growth and tumor development (7) . Nonetheless, the cellular events selectively controlled by p110␤ remain unknown.
DNA replication controls the accurate, timely duplication of the cell genome each time the cell divides. Preparation for replication requires formation of the origin replication complex (ORC) at the DNA replication origin. The ORC acts as a scaffold for assembly of the prereplicative complex that includes Cdc6 and Cdt1, proteins involved in recruitment of the minichromosome maintenance (MCM) complex exhibiting helicase activity. When MCM is loaded into the ORC, the pre-RC is licensed to initiate replication (8) (9) (10) (11) (12) . After licensing, replication initiation involves formation of the preinitiation complex, which requires activation of Cdk2 and Dbf4/ Cdc7 kinases (13) . These kinases phosphorylate the MCM and induce binding of DNA polymerase (Pol)␣/primase, which triggers primer DNA synthesis (11) . Elongation of DNA synthesis requires subsequent binding of the proliferating cell nuclear antigen (PCNA), a homotrimeric factor that triggers Pol␣ displacement and tethers the processive polymerases (␦ and ) to the DNA template for rapid, accurate DNA elongation (9, 14) . We examine here the function of p110␣ and ␤ in DNA replication.
Results and Discussion
The p110␤ Controls S-Phase Progression. p110␣ regulates G1 entry and cell growth (1); both p110␣ and ␤ regulate late G1 events and accelerate G1ϾS transition (6) ; however, no p110␤-specific function has been described in cell division. To examine the potential p110␤ action in this process, we compared the division rates of NIH 3T3 stable cell lines expressing p110␣ or ␤ active forms (Fig. 1A) . Active p110␤ cells divided more rapidly (t 1/2 Ϸ18 h) than active p110␣ cells or controls (t 1/2 Ϸ24 h; Fig. 1B ). In addition, although a small fraction of active p110␣ and ␤ cells enter cell cycle after serum deprivation (6) , only active p110␤ cells escaped cell contact inhibition in confluence (Fig. S1 A) . We also compared synchronous cell cycle progression in these cells. Cells were first serumdeprived (G0 arrest) and released by serum addition; using this protocol, NIH 3T3 cells reach S phase at Ϸ9 to 12 h postrelease (15) . Active p110␤ cells were faster in terminating S phase than control or active p110␣ cells ( Fig. 1C; Fig. S1B ), as confirmed by calculation of S phase duration (4 Ϯ 0.5 h for active p110␤ cells vs. 5.5-6 h for active p110␣ cells and Ϸ6 h for control cells); three distinct clones behaved similarly.
We also examined the consequences of reducing endogenous p110␣ and ␤ activity using inactive K802R-p110␣ and K805R-p110␤ mutants (KR hereafter) (6) . Expression of KR mutants in exponentially growing NIH 3T3 cells reduced PKB phosphorylation (pPKB, Fig. 1D ) and affected cell division; we were unable to prepare stable KR-p110␣ or ␤ lines. We expressed KR mutants by retroviral infection (95% efficiency), which yielded levels similar to endogenous p110 proteins (Fig. 1D) . Cell division was significantly slower in KR-p110␤ cells (Fig. 1E) , which remained in S phase for prolonged periods ( Fig. 1F; Fig. S1C ) and showed a longer S phase (Ϸ6 h control cells; 6-6.5 h KR-p110␣ cells, Ϸ8 h for KR-p110␤ cells).
p110␤ expression did not vary appreciably throughout the cell cycle. We examined the consequences of reducing p110␤ expression using various shRNA and protocols in NIH 3T3 cells and human U2OS cells (Methods). Whereas efficient protocols for p110␤ deletion interfered with cell viability, partial p110␤ reduction permitted cell cycle progression studies. To reduce p110␤ expression in U2OS cells, we stably transfected pTER-shRNA vectors, which allow inducible shRNA expression (16) . shRNA reduced p110␣ and ␤ levels even before induction, but reduction was greater after doxycycline treatment (Fig. 1G ). U2OS cells were synchronized at G1/S boundary by double thymidine block and examined S phase progression after release. We confirmed slower cell cycle entry in cells with reduced p110␣ or ␤ levels (6); in addition, only the cells with reduced p110␤ levels remained in S phase for prolonged periods, showing a Gaussian peak at mid-S phase DNA content at 6-7 h postrelease (Fig. 1G) .
We used the selective inhibitors PIK75 and TGX221 to inhibit p110␣ and ␤, respectively (17, 18) . We confirmed inhibitor selectivity in NIH 3T3 cells (Fig. S2 A-D) . Inhibition using 0.5 M PIK resulted in complete blockade of S phase entry and triggered apoptosis (Fig. S2E) , showing that p110␣ is needed for cell survival (19) . p110␣ inhibition (0.08 M PIK) near S phase permitted cell cycle entry (Fig. S2F) although it impaired G2/M entry, suggesting that p110␣ could be the isoform that acts in mitosis (1). This treatment nonetheless allowed S phase progression, as indicated by the increased proportion of S phase cells and displacement of the S phase population from near-G1 to near-G2 DNA content over the time course (Fig. S2F) . In contrast, selective inhibition of p110␤ permitted G2/M entry but extended S phase compared with controls (Fig. S2F) .
The p110␤ Activity Controls DNA Elongation. To compare S phase progression rates more accurately we BrdU-labeled (1 h pulse) newly synthesized DNA in exponentially growing cells and collected cells at various times after BrdU deprivation. While most BrdU ϩ control and KR-p110␣ cells reached G2/M at 3 to 5 h, the majority of BrdU ϩ KR-p110␤ cells remained in S phase at 5 h (Fig. S3A) . We examined the consequences of impaired p110␤ function on DNA elongation with the DNA combing assay (20, 21) . We used PI3K inhibitors, as they permit p110␣ or ␤ blockade in late G1 without affecting prior events. G0-synchronized NIH 3T3 cells were serum-released, treated with PIK 75 (0.08 M) or TGX 221 (30 M) at 7 h, BrdUlabeled (20 min) at 12 h, then collected to examine the replication profile ( Fig. 2A) . For each sample, we analyzed Ϸ30 MB of individual DNA fibers (Ͼ250 kb). TGX-treated cells showed 43% reduction in the length of BrdU tracks relative to controls, suggesting that p110␤ is required for normal replication fork progression; in contrast, elongation was not significantly affected by p110␣ inhibition (Fig. 2 A) . Median center-to-center distance between adjacent BrdU tracks, indicative of the initiation rate, was shorter in TGXthan in PIK-treated cells or in controls (Fig. 2B) , consistent with cell activation of additional replication origins to compensate slow fork progression (21) . The percentage of replication of individual DNA fibers was lower in TGX-(20.7%) than in control or PIK-treated cells (33.0 and 32.3%). These Time from G0, h results suggest that p110␤ activity controls replication fork progression.
The p110␤ Is Located in the Nucleus and Controls PCNA Binding to
Chromatin. Since DNA replication occurs in the nucleus, we examined p110␤ localization. Subcellular fractionation (Methods) and immunofluorescence analysis showed that the majority of endogenous p110␤, but not of ␣, concentrated in the NIH 3T3 cell nucleus (Fig. 2C ). Both the nuclear p110␤ signal and the mainly cytosolic p110␣ signal decreased with selective shRNA ( Fig. 2C ; Fig. S3B ).
A similar distribution was observed in MEF, COS-7, HeLa and U2OS cells. These results indicate that p110␤ concentrates in the nucleus. We examined the mechanisms by which p110␤ regulates replication. One of the first events required to initiate replication is MCM complex loading on origins (replication licensing, 8, 13, 22) . We compared MCM loading to chromatin by cell fractionation on nuclear and chromatin extracts (23) . Whereas in control cells, MCM 2/4 appeared on chromatin fractions in exponential growth, but not after GF starvation or in confluence, active p110␣ or ␤ expression induced a similar and moderate enhancement of MCM 2/4 loading onto chromatin in starving and confluence conditions (Fig. S3C) . Accordingly, KR-p110␣ or ␤ expression induced a slight reduction in late G1 MCM loading (Fig. 3A) . MCM loading onto chromatin is thus modulated to some extent by p110␣ and ␤, but is not selectively controlled by p110␤.
The p110␤ Activity Regulates PCNA Loading onto Chromatin. After replication origin activation, Pol␣ binding to the ORC triggers primer DNA synthesis; elongation of DNA synthesis requires subsequent binding of PCNA that tethers the processive polymerases Pol␦ and to the DNA template (9, 14) . In control synchronized NIH 3T3 cells, we observed PCNA appearance in chromatin extracts (22) as well as PCNA-Pol␦ association at Ϸ12 h after GF addition, at the onset of S phase (Fig. 3B) . Active p110␣ cells behaved similarly; in contrast, active p110␤ expression accelerated PCNA binding to chromatin and PCNA-Pol␦ association (Fig. 3B) . Moreover, expression of KR-p110␤ (Fig. 3C) , reduction of p110␤ levels with shRNA ( Fig. 3D; Fig. S3D ) and p110␤ inhibition (Fig. S3 E and F) diminished PCNA loading onto chromatin as well as PCNA-Pol␦ association; interference with p110␣ only had a modest inhibitory effect. These data show that p110␤ controls PCNA binding to chromatin and to Pol␦, providing a potential mechanism for DNA elongation impairment after interference with p110␤ function.
The p110␤ Activity Regulates p21 Cip Phosphorylation. PCNA loads Pol ␦ and to the DNA template for efficient elongation; PCNA also binds p21
Cip through the same region, p21 Cip thus impairs PCNA association to Pol␦/ (22, 24) . We examined PCNA-p21 Cip complex formation in cells with altered p110␤ activity. Whereas interference with p110␣ did not appreciably affect PCNA-p21 Cip complexes, active-p110␤ reduced (Fig. 3E ) and inactive p110␤ (or p110␤ inhibition) increased PCNA-p21
Cip association (Fig. 3F, Fig.  S4A ). Phosphorylation of p21
Cip on T145 and Ser-146 phosphorylation (by PKB and PKC) regulates its dissociation from PCNA (25) (26) (27) (28) , nonetheless, in vivo T145 appears to be the critical residue (27, 28) . We confirmed that T145 phosphorylation induced PCNAp21
Cip dissociation in U2OS cells and NIH 3T3 cells (Fig. 4A) ; expression of the phosphomimetic D145-p21
Cip mutant reduced PCNA-p21
Cip association increasing PCNA binding to chromatin (Fig. 4A) .
We also examined whether p110␤ regulates T145 phosphorylation. Whereas in control cells T145 was phosphorylated near S phase entry, both p110␤ shRNA and KR-p110␤ expression reduced pT145-p21
Cip levels ( Fig. 4B; Fig. S4 B-D) . In these assays we observed that interference with p110␤ activity also resulted in greater p21
Cip expression levels. p21 Cip is degraded after its release from PCNA (29) ; the higher p21
Cip levels in cells with impaired p110␤ function might be due to stabilization of p21
Cip in complex with PCNA. Both KR-p110␤ and p110␤ shRNA expression increased p21
Cip protein stability (Fig. S5A) , whereas active p110␤ reduced p21 cip stability (Fig. S5B ). p110␤ activity is thus needed for p21
Cip phosphorylation and dissociation from PCNA.
The p110␤ Regulates Nuclear PKB. The PI3K effector PKB phosphorylates T145-p21 Cip (27, 28) . We confirmed that PKB phosphorylates T145-p21
Cip in vitro (Fig. S6A ) and examined whether p110␤ regulates PKB-mediated T145-p21
Cip phosphorylation. We found that expression of KR-p110␤ (or p110␤ inhibition) reduced S phase PKB kinase activity in vitro (Fig. S6 A and B) . Western blot analysis of pPKB in extracts from synchronized NIH 3T3 cells expressing KR-p110␤ or treated near S phase with TGX221 confirmed that p110␤ regulates S phase pPKB, whereas p110␣ inhibition had a lesser effect (Fig. 4C) ; results were similar in U2OS cells (Fig. S6C) . As an alternative approach, we examined pPKB by immunofluorescence. At 1 h postserum addition (G1 phase) pPKB concentrated at the cell membrane and was reduced by KR-p110␣ (Fig. S7A) , whereas in S phase pPKB concentrated in the nucleus and was notably reduced by KR-p110␤ and p110␤ inhibition ( Fig.  4D; Fig. S7B ). Cell fractionation confirmed TGX inhibition of S phase nuclear pPKB (Fig. S7C) .
We examined other PKB substrates in S phase; GSK3␤ phosphorylation was reduced by p110␤ inhibition, whereas FKHRL1 phosphorylation was p110␣ activity-dependent (Fig. S7D) , as is the case in G1 phase (6) . WB using anti-pPKB substrate Ab showed that p110␤ inhibition reduced phosphorylation of some PKB substrates in S phase cells (such as p21 Cip , Fig. S7C ), while others were p110␣-regulated (Fig. S7D) . Results were similar using S phase U2OS cells treated with PI3K inhibitors and then fractionated (Fig. 4E) ; this assay also showed that p110␣ inhibition affected mainly cytosolic substrates and p110␤ nuclear substrates, suggesting that p110␣ and ␤ control distinct PKB pools. p110␤ thus governs nuclear S phase PKB activity. Since p110␣ is activated at the G1/S boundary (6), the early timing of phosphorylation of some PKB substrates or their cytosolic localization might determine a p110␣ activity requirement for phosphorylation.
Based on p110␤ regulation of S phase nuclear pPKB-mediated p21 Cip phosphorylation, expression of the phosphomimetic D145-p21 Cip mutant in cells with impaired p110␤ activity could replace p110␤ activity in S phase. BrdU labeling of newly-synthesized DNA in exponentially growing cells expressing KR-p110␤ alone or in combination with D145-p21 Cip showed that D145-p21
Cip expression accelerated S phase progression in KR-p110␤ cells (Fig. 4F) . D145-p21 Cip expression also increased PCNA-Pol␦ association and reduced PCNA-p21 Cip complexes in KR-p110␤ cells (Fig. S8A) . Accordingly, A145-p21 Cip expression corrected PCNA-Pol␦ complexes in active p110␤ cells (Fig. S8B) . Thus, expression of phosphomimetic p21 Cip mutants corrects the S phase defects of cells with altered p110␤ activity.
PI3K␤ Protein
Regulates PCNA Loading onto Chromatin. The recently described conditional p110␤ Ϫ/Ϫ mouse phenotype and that of inactive p110␤ knock-in mice (7, 30) indicate that p110␤ kinase activity regulates mouse growth and tumor development and also that p110␤ has a kinase-independent function in embryonic development. Kinase-independent functions often reflect the ability of a protein to associate a necessary partner, as is the case for PI3K␥ in the control of cardiac stress response (31) . We examined whether p110␤ expression (independent of its kinase activity) regulates DNA elongation, studying the extent of PCNA binding to chromatin after p110␤ inhibition or p110␤ knockdown. To improve p110␤ deletion, we transfected cells with puromycin-shRNA-encoding vectors, selected them for 48 h and immediately analyzed these asynchronous cultures (synchronization requires longer culture times) before reduction of cell viability. Pulse-chase BrdU analysis in exponentially growing NIH 3T3 cells showed that p110␤ inhibition reduced S phase progression, but p110␤ knockdown had a greater effect in decelerating S phase (Fig. 5A) . PCNA loading onto chromatin was also reduced by p110␤ or PKB inhibition, but was drastically diminished by p110␤ knockdown (Fig. 5B) .
We also analyzed asynchronous cultures of p110␤ Ϫ/Ϫ immortalized mouse embryonic fibroblasts (MEF) reconstituted with WT or KR-p110␤ (7). KR-p110␤ MEF progressed through S phase more slowly than WT p110␤ MEF, although p110␤ Ϫ/Ϫ MEF showed the slowest S phase progression (Fig. 5A) . KR-p110␤ MEF had less chromatin-bound PCNA than controls, but PCNA loading was lowest in p110␤ Ϫ/Ϫ MEF (Fig. 5B) . These results suggest that PCNA loading onto chromatin and in turn S phase progression rate is further regulated via a kinase-independent p110␤ function. pPKB was little affected by p110␤ deletion in asynchronous cultures (7) . To define whether p110␤ controls nuclear PKB in S phase in these MEF, we synchronized cells at the G1/S border and examined them after release. In WT p110␤-reconstituted MEF, pPKB was found mainly in the nuclear fraction in S phase; KR-p110␤ MEF behaved similarly but had lower nuclear active pPKB levels (Fig. 5C ). Both nuclear pPKB and PKB were undetectable in p110␤ Ϫ/Ϫ MEF (Fig. 5C ), indicating that p110␤ expression might control PKB nuclear entry. Cytosolic pPKB was more abundant in p110␤ Ϫ/Ϫ MEF, but they expressed lower levels of PTEN (Fig. 5C) ; this might represent a compensatory mechanism for p110␤ deletion. We also analyzed nuclear/cytoplasmic distribution of pPKB and PKB in NIH 3T3 cells to further examine whether p110␤ deletion reduces not only nuclear phospho-PKB but also nuclear PKB, as in MEF. p110␤ shRNA diminished but did not completely eliminate nuclear PKB (Fig. S8C) . These results do not demonstrate, but suggest that PKB nuclear entry is facilitated by p110␤ expression, an aspect that requires further study. In contrast, both p110␤ inhibition and p110␤ shRNA expression clearly reduced S phase nuclear pPKB (Fig. S8C) , further confirming the function of p110␤ in control of nuclear PKB activity in S phase.
PI3K␤ Protein Associates PKB and PCNA. To determine whether p110␤-dependent PKB nuclear activity is due to direct association, we studied PKB-p110␤ complex formation in cytosolic and nuclear fractions. Cells were fractionated as described (32) , since the method used earlier (Fig. 2C ) (33) destroys protein-protein interactions. NIH 3T3 cells were cotransfected with HA-gagAKT and WT-p110␣ or -␤, collected at 12 h post-G0 release, and examined. Although PKB and p110␣ associated in cytosol, this association was lower than that of PKB and p110␤, and was not found in the nucleus, where only PKB-p110␤ complexes were observed (Fig.  S9A) . We also analyzed association of endogenous proteins in synchronized NIH 3T3 cells collected at 12 h postserum addition. WB analysis of the fractions confirmed that p110␣ was mainly cytosolic and p110␤ was more abundant in the nucleus (Fig. 5D) . Although immunoprecipitation concentrated the scarce nuclear p110␣ protein, endogenous PKB associated mainly with p110␤ in the nuclear fraction (Fig. 5D ).
To identify other nuclear proteins that regulate DNA replication and associate to p110␤, we performed a pull-down assay using mammalian GST-p110␤; we obtained a number of candidate proteins including PCNA. Immunoprecipitates of endogenous PCNA from nuclear extracts contained associated endogenous p110␤ but not p110␣ (Fig. 5E) ; results were similar in a reciprocal assay (Fig. S9B) . To determine whether the selective association of PCNA with p110␤ was due to a p110␤-specific structural feature or to its subcellular distribution, we inserted a nuclear localization signal (NLS) in p85 and cotransfected it with myc-WT-p110␣ or -␤, which increased their nuclear localization. Both nuclear p110␤ and ␣ associated with PCNA, although p110␤ association to PCNA was greater than that of nuclear p110␣ (Fig. S9C) . Therefore, in addition to its subcellular distribution, p110␤ has a structural advantage for association to PCNA.
Here, we describe a role for p110␤ in replication fork elongation in mammalian cells, providing an example of elongation control by extracellular signal-regulated molecules. The nuclear localization and function of p110␤ resembles that of class IV PI3K, which are recruited to DNA damage sites and mediate cell responses as DNA repair (34) . Although some cell cycle phenotypes were moderate (Fig. 1) , complete p110␤ elimination interfered with cell survival, and p110␤ function was studied in partial p110␤ deletion conditions. p110␤ regulated DNA replication through kinase-dependent and -independent mechanisms. p110␤ associated with PKB, and p110␤ activity regulated nuclear PKB-mediated p21
Cip phosphorylation, PCNA release, PCNA binding to Pol␦ and replication elongation. Interference with p110␣ activity had a slight inhibitory effect on p21 Cip phosphorylation, and might partially compensate for p110␤ activity-dependent functions. In addition, p110␤ associated with PCNA and controlled PCNA loading onto chromatin in Lysates of cells treated as in A were analyzed in WB to determine PCNA in the chromatin fraction, as well as PCNA and p110␤ in the chromatin-free fraction. Graphs show the percentage of chromatin-bound PCNA normalized to total PCNA and compared with maximum signal in control NIH 3T3 or in MEF. (C) Immortalized MEF as in A were arrested by thymidine treatment, then released for different times. Cell fractions were examined in WB to test for pPKB and PKB levels; the latter was then reprobed for PTEN. The graphs show nuclear pPKB or PKB signal in arbitrary units (AU) (mean Ϯ SD, n ϭ 3). (D) Synchronized NIH 3T3 cell cultures collected at 12 h postserum addition were fractionated. The levels of PKB, p110␣ and ␤ in these fractions were examined by WB (Left). Endogenous p110␣ or ␤ from cytosolic (1500 g) and nuclear extracts (600 g), or PKB from cytosolic (300 g) and nuclear extracts (200 g) were immunoprecipitated. We tested for PKB and p85 in p110 immunoprecipitates by WB. Controls 1-3, protein A plus each of the antibodies. Graph shows the percentage of p110-associated PKB signal, compared with maximal PKB signal (in PKB immunoprecipitates from an equivalent protein amount). (E) Nuclear fractions were obtained from synchronized NIH 3T3 cells (at 12 h). PCNA (800 g) or p110 (200 g) immunoprecipitates were tested in WB for p110. For control 1, protein A was incubated with Ab; control 2, protein A was incubated with lysate. Graphs show the percentage of p110 signal in PCNA immunoprecipitates compared with maximal p110 signal (p110 immunoprecipitated from an equivalent protein amount). * , P Ͻ 0.05. a kinase-independent manner. Since PCNA loading onto chromatin is essential for DNA duplication, this kinase-independent function explains the greater division defects in cells with reduced p110␤ expression. The role of p110␤ in DNA replication could contribute to cause the early lethality (E2-3, ref.4) of p110␤-deficient mice.
Materials and Methods
Complementary DNA and shRNA. pSG5-p110␣CAAX (active p110␣), pSG5-HAwt-PKB and -gag-PKB were described (5, 35) . pCEF2-hp110␤CAAX (active p110␤) was a gift of Dr. Murga (Centro de Biología Molecular/CSIC, Madrid, Spain). PcDNA-Myc -WT and p21 Cip mutants were donated by Dr. Rö ssig (28) . pcDNA Myc-S146A/T145A double mutant was generated using Quick Change SiteDirected mutagenesis (Stratagene). Myc-K802R-hp110␣ and myc-K805R-hp110␤ mutants were subcloned into pSG5 and pRV-IRES-GFP for retroviral infection (6) . We used several specific short hairpin RNA (shRNA) directed to human or murine p110 sequences, each assay was performed at least with two shRNA, with similar results. These shRNA (6) were subcloned in pBluescript/U6 or in pTER vector; we used control shRNA that did not reduce p110␣ or ␤ expression. We also used Pik3cb shRNA (Origene; Fig. 5 ). To prepare NLS-p85, the PKKKRKV sequence was inserted 3Ј of the p85 sequence.
Cell Lines, Cell Culture, and Retroviral Transduction. Active p110␣ and active p110␤ NIH 3T3 cells lines were described (6) . KR-p110␣ and ␤ mutations were transduced by transient transfection or retroviral infection. We generated pTERp110␣ or pTER-p110␤ U2OS clones according to manufacturer's protocol (Invitrogen); shRNA expression was induced for 2 days (p110␣) or 5 days (p110␤) in medium plus doxycycline (6 g/mL, Sigma). NIH 3T3 murine fibroblasts, U20S and COS7 cells were cultured as described (6) . For retrovirus production, Phoenix cells were transfected using JetPei-NaCl (Qbiogene). MEF were donated by Drs. Zhao and Roberts (7) (Dana Farber Cancer Institute, Boston, MA).
Cell Cycle, BrdU Labeling, Immunofluorescence, and Dynamic Molecular Combing. Immunofluorescence and NIH 3T3 G0 synchronization were as reported (15) . Briefly, cells were incubated in serum-free medium (19 h ) and released by serum addition. Cell cycle distribution was examined by DNA staining with propidium iodide and analyzed by flow cytometry (Beckman-Coulter) using Multicycle AV (Phoenix Flow Systems). Cells were synchronized at G1/S by double thymidine block (6) or using aphidicolin (22) . To determine cell division time (t1/2), cells were seeded at similar densities and counted at 24 h intervals. S phase duration was calculated considering t 1/2 (mean of n ϭ 6) and the proportion of cells in S phase in exponential growth (mean of n ϭ 12). S phase progression rates were examined in exponentially growing cultures incubated with 20 M bromodeoxyuridine (BrdU; 1 h), chased at different times and stained with BrdU-FITC Ab (BD Biosciences), then examined by three-dimensional FACS.
For dynamic molecular combing, synchronized NIH 3T3 cells were treated with 0.08 M PIK75 or 30 M TGX221 at 7 h postserum addition; 20 min before harvest (12 h postserum addition), cells were treated with 20 M BrdU. After harvest, cells were embedded in LMP agarose plugs (3 ϫ 10 6 cells/plug) and DNA fibers were purified and stretched on silanized coverslips as described (21) . BrdU tracks were detected with rat monoclonal Ab (clone BU1/75; AbCys) and an Alexa 488-conjugated secondary Ab (Molecular Probes). DNA fibers were counterstained with mouse anti-ssDNA (MAB3034, Chemicon) and Alexa 546-secondary Ab (Molecular Probes). Signals were analyzed with MetaMorph.
Statistical analyses were performed using StatView 512ϩ (Calabasas, CA). Gel bands and fluorescence intensity were quantitated with ImageJ software. Statistical significance was calculated using Student's t test. For DNA combing, statistical analysis was performed with GraphPad Prism 5.0 (GraphPad Software).
For description of antibodies and reagents, cell lysis, subcellular fractionation, Western blotting, immunoprecipitation, and kinase assays, see SI Methods.
